Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Other Operating Expenses (2020 - 2025)

Celularity has reported Other Operating Expenses over the past 6 years, most recently at $4.3 million for Q3 2025.

  • Quarterly results put Other Operating Expenses at $4.3 million for Q3 2025, up 0.52% from a year ago — trailing twelve months through Sep 2025 was $21.3 million (up 528.9% YoY), and the annual figure for FY2024 was $16.5 million, down 87.65%.
  • Other Operating Expenses for Q3 2025 was $4.3 million at Celularity, down from $5.6 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for CELU hit a ceiling of $87.1 million in Q3 2023 and a floor of -$45.7 million in Q3 2021.
  • Median Other Operating Expenses over the past 5 years was $4.3 million (2024), compared with a mean of $1.8 million.
  • Peak annual rise in Other Operating Expenses hit 9186.17% in 2021, while the deepest fall reached 930.33% in 2021.
  • Celularity's Other Operating Expenses stood at -$18.1 million in 2021, then plummeted by 140.08% to -$43.4 million in 2022, then surged by 67.76% to -$14.0 million in 2023, then surged by 153.76% to $7.5 million in 2024, then tumbled by 43.13% to $4.3 million in 2025.
  • The last three reported values for Other Operating Expenses were $4.3 million (Q3 2025), $5.6 million (Q2 2025), and $3.9 million (Q1 2025) per Business Quant data.